PharmaceuticalDepressantBenzodiazepineSedative

Midazolam (Versed)

Also known as Versed · Buccolam · Hypnovel

Written by enwyReviewed 15 Jul 20262 sources0 comments

Midazolam is a short-acting, water-soluble benzodiazepine used mainly for procedural sedation, anaesthesia induction, and acute seizure control. Though usually given parenterally or buccally in hospital, an oral form exists; it carries strong sedation, amnestic effects, and respiratory depression risk.

01 Overview

Midazolam enhances GABA-A signalling with a rapid onset and short duration, making it ideal for procedural sedation, pre-medication, and status epilepticus. Its water solubility at low pH allows convenient parenteral and mucosal administration.

Dependence is less of a concern with the brief procedural use it is designed for, but tolerance and withdrawal can occur with prolonged infusion (for example in intensive care). Its most important acute hazards are pronounced anterograde amnesia and respiratory depression, which is markedly potentiated by opioids and alcohol.

02 Mechanism

Positive allosteric modulator of the GABA-A receptor with rapid onset; produces sedation, amnesia, anxiolysis and anticonvulsant effects.

03 Dosing

Tier	Dose	Route	Notes
Light (paediatric premed)	5–7.5 mg	Oral	Oral premedication; dose often weight-based in children.
Common (premed)	7.5–15 mg	Oral	Oral pre-procedure sedation in adults.
Therapeutic	7.5–15 mg	Oral	Given under monitoring; parenteral/buccal routes more common clinically.

04 Effects

Effect	Magnitude	Evidence
SedationReliable procedural and pre-operative sedation.	Rapid onset	Clinical
Anterograde amnesiaBlocks memory of the procedure; therapeutically useful but also a risk.		Clinical
AnticonvulsantUsed (buccal/IV) to terminate prolonged seizures.		Clinical

05 Side effects

Effect	Severity	Frequency	Evidence
Respiratory depressionDose-related respiratory and CNS depression, markedly increased with opioids or alcohol.	Life-threatening	Common in sedation setting	Clinical
Dependence and withdrawal (prolonged use)Tolerance and withdrawal (including seizures) after prolonged ICU infusion; abrupt cessation should be avoided.	Severe	Uncommon; seen with prolonged infusion	Clinical
Anterograde amnesia and confusionImpaired memory formation and post-procedure confusion.	Moderate	Very common	Clinical

06 Legal status

United States

Schedule IV controlled substance

Prescription/hospital use only. · as of Jan 2026

United Kingdom

Class C, Schedule 3 (Misuse of Drugs)

Prescription only; hospital-administered. · as of Jan 2026

07 References

MidazolamStatPearls / NCBI Bookshelf

Midazolam label informationUS FDA / DailyMed

08 Discussion0 comments

Create account

Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.

This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.